APMA Grants Seal of Approval for JUBLIA® (efinaconazole) Topical Solution, 10%
- Monday, December 6, 2021, 7:10
- PR Newswire
- Add a comment
LAVAL, QC, Dec. 6, 2021 /PRNewswire/ — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced JUBLIA® (efinaconazole) Topical Solution, 10%, a…
About the Author
admin has written 20663 stories on this site.